EPCORITAMAB + R-CHOP CUTS THE RISK OF PROGRESSION OR DEATH BY 51%: BISPECIFICS ARE MOVING FROM “SALVAGE” TO FRONTLINE DLBCL... Read more
Category: Uncategorized
GE HEALTHCARE BUYS SOFIE FOR $945 MILLION: IN RADIOPHARMA, THE “LAST MILE” IS BECOMING A COMPETITIVE MOAT
Key Development GE HealthCare has agreed to acquire SOFIE Biosciences for $945 million in cash, adding a U.S. PET radiopharmaceutical... Read more
108–DIAKOVERE ANNASTIFT: VIETNAM–GERMANY ORTHOPEDIC COOPERATION COULD MOVE FROM “TECHNOLOGY TRANSFER” TO “TECHNOLOGY CO-DEVELOPMENT”
Key Development Vietnam's Military Central Hospital 108 and DIAKOVERE Annastift in Hannover have established a formal orthopedic cooperation framework, but... Read more
VIET DUC PERFORMS ITS FIRST ROBOTIC-ASSISTED KNEE REPLACEMENT: THE REAL VALUE IS NOT GREATER PRECISION — IT IS TURNING PRECISION INTO BETTER OUTCOMES
Key Development Viet Duc University Hospital has performed its first robot-assisted total knee replacement, marking another step in the adoption... Read more
AI COULD GIVE NURSES TIME BACK: THE REAL RACE IS NOT “REPLACING PEOPLE” — IT IS REMOVING WORK THAT ADDS LITTLE CLINICAL VALUE
Key Development Research highlighted by RMIT positions large language models in a more pragmatic role than the broader “AI replacing... Read more
ROCHE PUTS UP TO $1.27 BILLION BEHIND AL050: THE PARKINSON’S RACE IS MOVING FROM REPLACING DOPAMINE TO REPAIRING DISEASE BIOLOGY
Key Development Genentech, a member of the Roche Group, has licensed Alector's AL050 globally — a brain-penetrant glucocerebrosidase, or GCase,... Read more
VAX-31 CLEARS PHASE 3 OPUS-1: THE PNEUMOCOCCAL VACCINE RACE IS SHIFTING FROM “MORE SEROTYPES” TO “BROADER COVERAGE WITHOUT IMMUNE TRADE-OFFS”
Key Development Vaxcyte has passed the most important test yet for VAX-31: whether a 31-valent pneumococcal conjugate vaccine can materially... Read more
2026 MEDICINE NOBEL HONORS OPTOGENETICS: ITS BIGGEST VALUE MAY NOT BE “TREATING THE BRAIN WITH LIGHT” — BUT SHOWING DRUGMAKERS WHICH CIRCUITS ACTUALLY MATTER
Key Development Karl Deisseroth, Peter Hegemann and Georg Nagel have received the 2026 Nobel Prize in Physiology or Medicine for... Read more
LMS–MEDIZEN HUMANCARE: GENOMIC DATA COULD OPEN A “PRECISION PREVENTION” MARKET IN VIETNAM — BUT CLINICAL UTILITY WILL BE THE REAL MOAT
Key Development Longevity Medical System and South Korea's Medizen HumanCare have formed a strategic partnership to integrate genomic information into... Read more









